Thomas J. Shaw Purchases 33,524 Shares of Retractable Technologies, Inc. (NYSE:RVP) Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 33,524 shares of the company’s stock in a transaction that occurred on Friday, April 11th. The stock was purchased at an average price of $0.69 per share, for a total transaction of $23,131.56. Following the transaction, the chief executive officer now owns 15,201,112 shares of the company’s stock, valued at $10,488,767.28. The trade was a 0.22 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through this link.

Retractable Technologies Stock Performance

Shares of RVP stock opened at $0.69 on Thursday. Retractable Technologies, Inc. has a 52-week low of $0.56 and a 52-week high of $1.22. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The stock has a market cap of $20.75 million, a PE ratio of -1.28 and a beta of 2.28. The business has a 50-day simple moving average of $0.75 and a 200-day simple moving average of $0.73.

Analyst Ratings Changes

Separately, StockNews.com initiated coverage on shares of Retractable Technologies in a research note on Saturday, April 12th. They issued a “hold” rating on the stock.

Institutional Investors Weigh In On Retractable Technologies

A hedge fund recently raised its stake in Retractable Technologies stock. Renaissance Technologies LLC increased its position in shares of Retractable Technologies, Inc. (NYSE:RVP) by 9.4% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 361,253 shares of the company’s stock after buying an additional 31,140 shares during the period. Renaissance Technologies LLC owned 1.21% of Retractable Technologies worth $249,000 as of its most recent filing with the SEC. 7.58% of the stock is currently owned by institutional investors.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.